Cyclic amine phenyl beta-3 adrenergic receptor agonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 211/58 (2006.01) C07D 211/00 (2006.01) C07D 223/12 (2006.01) C07D 233/00 (2006.01) C07D 277/00 (2006.01) C07D 401/10 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/10 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 405/14 (2006.01) C07D 409/12 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/10 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2416245

This invention provides compounds of Formula (I) wherein: R1, R2, R3, R4, R5, T, T1, T2, and X are as defined hereinbefore, or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related to insulin resistance or hyperglycemia (typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension and frequent urination; and are particularly useful in the treatment or inhibition of type II diabetes.

L'invention concerne des composés représentés par la formule (I) dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, T, T?1¿, T?2¿, et X sont tels que définis dans la description, ainsi que des sels pharmaceutiquement acceptables de ces composés. Ces produits sont utilisés pour traiter ou inhiber des troubles métaboliques associés à la résistance à l'insuline ou à l'hyperglycémie (généralement associés à l'obésité et à l'intolérance au glucose), à l'athérosclérose, aux troubles gastro-intestinaux, à l'inflammation neurogénétique, au glaucome, à l'hypertension oculaire, et à des mictions fréquentes. Ils sont utilisés, en particulier, pour traiter ou inhiber les diabètes de type II.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic amine phenyl beta-3 adrenergic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic amine phenyl beta-3 adrenergic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic amine phenyl beta-3 adrenergic receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1597808

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.